---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-021941"
form_type: "8-K"
ticker: "SEER"
cik: "0001726445"
company_name: "Seer, Inc."
filed_at: "2022-08-09T23:59:59+00:00"
generated_at: "2026-06-24T02:10:20.376351+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Seer Q2 2022 revenue $3.6M, net loss $22.8M; guidance reaffirmed

## Summary
- Revenue $3.6M vs $1.3M YoY; product revenue $3.5M including $1.1M from related party.
- Net loss $22.8M vs $16.6M YoY; operating expenses $25.0M up from $17.4M.
- Cash, equivalents and investments $456.1M as of June 30, 2022.
- FY 2022 revenue guidance reaffirmed at $14M-$16M.
- Launched Proteograph Analysis Suite 2.0 for scalable proteogenomic analysis.

## SEC filing metadata
- accession: 0001628280-22-021941
- form_type: 8-K
- ticker: SEER
- cik: 0001726445
- company_name: Seer, Inc.
- filed_at: 2022-08-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1726445/000162828022021941/0001628280-22-021941-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1726445/000162828022021941/seer-20220809.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-021941
- JSON: https://secwatch.observer/filing/0001628280-22-021941.json
- Plain text: https://secwatch.observer/filing/0001628280-22-021941.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.